Is it time to consider self-testing for respiratory illness? At-home diagnostic medical devices have been floated as a potential way to ease the strain on public health, but experts say concerns remain.
Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.
Anti-vaxxer’s actions prompt TGA statement A recent incident saw an anti-vaccination advocate enter a general practice under false pretences to remove National Immunisation Program posters.
Decision to suspend implants may spark excessive breast cancer concern Concerned women with textured breast implants linked to a rare cancer are likely to seek advice from their GP, an expert has told newsGP.
‘Unexplained pharmaceuticals’ found in complementary and alternative medicines Nearly half of the 135 complementary and alternative medicines tested by researchers had contaminants, including animal DNA and potential allergens.
Opioid pack changes ‘long overdue’, but more reform needed From 2020, opioid packages will be smaller and feature improved labels with clearer warnings and consumer information.
Opioid marketing scrutinised by TGA, questioned by RACGP The Therapeutic Goods Administration has confirmed it is examining opioid marketing material aimed at GPs.
What should GPs know about bioidentical hormone therapy? Two experts answer common questions on compounding bioidentical hormone therapy for menopause.
Food labelling: When is a medicine not a medicine? Concerns have been raised over alleged double standards regarding the regulation of food products promoted as having ‘special medical purposes’.
TGA criticised over lack of safety warnings Questions have been raised over the way Australia’s therapeutic regulator is informing doctors and patients about potentially dangerous drugs.